TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Acura Pharmaceuticals ( (ACUR) ) has issued an announcement.
Acura Pharmaceuticals has received multiple loans from Abuse Deterrent Pharma, LLC, totaling $8,694,279 as of September 3, 2025, to support its operations. However, the company faces financial challenges and may need to scale back operations or seek bankruptcy protection if additional financing is not secured by mid-September 2025, potentially resulting in a complete loss of shareholder value.
More about Acura Pharmaceuticals
Average Trading Volume: 1,000
Technical Sentiment Signal: Sell
Current Market Cap: $19.87K
For detailed information about ACUR stock, go to TipRanks’ Stock Analysis page.